Is Angion Biomedica Corp. (ANGN) a Buy, Sell, or Hold?
NASDAQ : ANGN
Angion Biomedica Corp. — Institutional Ownership
$1 USD
$0 (0.0%)
- Volume
- 224.8K
- Average Volume
- 9.65K
- Market Capitalization
- $30.11M
- P/E Ratio
- -0.42
- Dividend Yield
- 0.00%
- Price Target
- $1.50
- Year High
- $20.40
- Year Low
- $1.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.24
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-07-16 | Moti Investments LLC | 1.41M | 6.10% |
| 2025-10-07 | Actyus Private Equity SGIIC, S.A. | 268.56K | 1.60% |
| 2025-03-07 | Yekaterina Chudnovsky | 9.66M | 48.10% |
| 2025-02-05 | Knoll Capital Management, LLC | 630.92K | 5.20% |
| 2025-01-07 | Actyus Private Equity SGIIC, S.A. | 587.82K | 5.45% |
| 2023-06-14 | Yekaterina Chudnovsky | 707.16K | 8.40% |
| 2023-06-14 | GKCC, LLC | 702.64K | 8.40% |
| 2023-06-12 | Access Industries Management, LLC | 689.57K | 7.11% |
| 2023-06-12 | Access Industries Holdings LLC | 689.57K | 7.11% |
| 2023-06-12 | Len Blavatnik | 689.57K | 7.11% |
| 2023-06-12 | Access Industries, LLC | 689.57K | 7.11% |
| 2023-06-12 | Clal Biotechnology Industries Ltd. | 689.57K | 7.11% |
| 2023-06-12 | Clal Industries Ltd. | 689.57K | 7.11% |
| 2022-05-19 | Thomas A. Satterfield, Jr. | 1.57M | 5.30% |
| 2022-04-27 | Itzhak D. Goldberg | 1.82M | 6.00% |
| 2022-04-27 | Jay R. Venkatesan | 2.9M | 9.30% |
| 2022-03-30 | Vifor Pharma Ltd. | 2M | 6.70% |
| 2022-03-30 | Vifor Fresenius Medical Care Renal Pharma Ltd. | 2M | 6.70% |
| 2022-03-30 | Vifor (International) Ltd. | 2M | 6.70% |
| 2022-02-14 | EISA-ABC, LLC | 1.72M | 5.70% |
ANGN Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1.00 | 15.31M | $15.31M | $18.56M | $5.1M | $1.85M |
| 2024-12-31 | $1.00 | 12.2M | $12.2M | $17.62M | $6.01M | $591K |
| 2023-12-31 | $1.00 | 25.98M | $25.98M | -$ | -$ | $25.98M |
| 2022-12-31 | $0.81 | 30.04M | $24.38M | $50.49M | $3.71M | -$22.4M |
| 2021-12-31 | $2.90 | 28.24M | $81.91M | $88.76M | $4.66M | -$2.18M |
| 2020-12-31 | $17.02 | 28.78M | $489.84M | $34.61M | $56.52M | $511.75M |
| 2019-12-31 | $17.02 | 16.9M | $287.63M | $5.57M | $10.78M | $292.84M |
| 2018-12-31 | $17.02 | 15.36M | $261.49M | $25.51M | -$ | $235.98M |
| 2013-12-31 | $17.02 | 16.9M | $287.63M | $2.06M | $5.32M | $290.9M |
| 2012-12-31 | $17.02 | 16.9M | $287.63M | $1.4M | $5.44M | $291.67M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1.00 | 18.21M | $18.21M | $14.95M | $4.86M | $8.13M |
| 2025-12-31 | $1.00 | 15.31M | $15.31M | $18.56M | $5.1M | $1.85M |
| 2025-09-30 | $1.00 | 16.69M | $16.69M | $20.61M | $5.34M | $1.42M |
| 2025-06-30 | $1.00 | 16.06M | $16.06M | $22.09M | $5.56M | -$463.58K |
| 2025-03-31 | $1.00 | 12.95M | $12.95M | $18.35M | $5.79M | $390.57K |
| 2024-12-31 | $1.00 | 12.2M | $12.2M | $17.62M | $6.01M | $591K |
| 2024-09-30 | $1.00 | 13.58M | $13.58M | $26.02M | $6.22M | -$6.22M |
| 2024-06-30 | $1.00 | 21.85M | $21.85M | $3.42M | $6.42M | $24.84M |
| 2023-09-30 | $1.00 | 25.98M | $25.98M | $14.84M | $7.15M | $18.29M |
| 2023-06-30 | $1.00 | 25.98M | $25.98M | $21.68M | $7.4M | $11.7M |
| 2023-03-31 | $0.58 | 30.11M | $17.47M | $29.22M | $297K | -$11.46M |
| 2022-12-31 | $0.81 | 30.04M | $24.38M | $50.49M | $3.71M | -$22.4M |